🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate that treatment with a 6-monthly...
Status
Terminated
Location
The Crouch Oak Family Practice
Start Date
2012-08
Trial ID
NCT01673984
Treatments Being Tested
Assess the efficacy and safety of Triptorelin pamoate 3M formulation (11.25...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01715129
Treatments Being Tested
The purpose of the protocol is to assess the efficacy of triptorelin 11.25 ...
Status
Completed
Location
Hôpital Hôtel Dieu (CHU)
Start Date
2008-04
Trial ID
NCT00909844
Treatments Being Tested
The active ingredient of Pamorelin® 11,25 mg is Triptorelin. Triptorelin is...
Status
Terminated
Location
Vrije Universiteit Medisch Centrum
Start Date
2007-02
Trial ID
NCT00444639
Treatments Being Tested
Chemotherapy drugs like alkylating agents are frequently used in various co...
Status
Completed
Location
Algemeen Ziekenhuis Stuivenberg
Start Date
2002-07
Trial ID
NCT01160315
Treatments Being Tested
The purpose of this study is to collect some parameters which may help to p...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT02238366
Treatments Being Tested
Adenomyosis is a benign condition defined as the invasion of ectopic endome...
Status
Withdrawn
Location
CHU Angers
Start Date
2022-04-29
Trial ID
NCT03940807
Treatments Being Tested
The purpose of the study is to assess the efficacy of triptorelin 11.25 mg ...
Status
Completed
Location
Hôpital Hotel-Dieu (CHU)
Start Date
2007-10
Trial ID
NCT00564850
Treatments Being Tested
Breast cancer (BC), especially premenopausal, is emerging rapidly in East A...
Status
Recruiting
Location
National Taiwan University Hospital
Start Date
2024-08-22
Trial ID
NCT06225284
The main objective of the trial is to explore the efficacy and safety of co...
Status
Active Not Recruiting
Location
Universitätsspital Basel
Start Date
2023-03-29
Trial ID
NCT05746806